Equivac® S

  • Sale
  • Regular price $63.09
Tax included. Shipping calculated at checkout.


Active Constituents

  •  250 µL/mL Streptococcus equi (as cell-free extract)

  • 0.1 mg/mL Thiomersal added

Indications

For protection against strangles caused by S. equi in horses.

To stimulate the immune system to produce antibodies against the antigens contained in the vaccine.

Contraindication
Equivac-S is for preventative control only and is of no value in the treatment of strangles.

Dosage & Administration

Horses:
Inject 1mL dose of vaccine intramuscularly. For primary immunisation, horses of 3 months of age or older should be given 3 doses of vaccine at intervals of not less than 2 weeks apart. 

All horses should receive annual booster doses of 1mL. Increased protection against strangles may be obtained by administering booster doses more frequently and six-monthly re-vaccination should be considered in circumstances where the risk of strangles is known to be high. It is particularly important that booster doses be given prior to periods of greater risk of infection, such as during the breeding season.

Pregnant mares:
May be vaccinated up to 2 weeks before foaling. In an outbreak of strangles, horses should be segregated into 3 groups. Those affected by the disease should be treated and not vaccinated. Horses with no known contact should be vaccinated immediately. Horses known to have been in contact should be observed for 7 to 10 days and vaccinated only if they have normal temperatures and show no clinical signs.